202 related articles for article (PubMed ID: 18997170)
1. HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism.
Kawase T; Matsuo K; Kashiwase K; Inoko H; Saji H; Ogawa S; Kato S; Sasazuki T; Kodera Y; Morishima Y;
Blood; 2009 Mar; 113(12):2851-8. PubMed ID: 18997170
[TBL] [Abstract][Full Text] [Related]
2. HLA-DPB1 mismatch induces a graft-versus-leukemia effect without severe acute GVHD after single-unit umbilical cord blood transplantation.
Yabe T; Azuma F; Kashiwase K; Matsumoto K; Orihara T; Yabe H; Kato S; Kato K; Kai S; Mori T; Morishima S; Satake M; Takanashi M; Nakajima K; Morishima Y;
Leukemia; 2018 Jan; 32(1):168-175. PubMed ID: 28652579
[TBL] [Abstract][Full Text] [Related]
3. The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis.
Mytilineos D; Tsamadou C; Neuchel C; Platzbecker U; Bunjes D; Schub N; Wagner-Drouet E; Wulf G; Kröger N; Murawski N; Einsele H; Schaefer-Eckart K; Freitag S; Casper J; Kaufmann M; Dürholt M; Hertenstein B; Klein S; Ringhoffer M; Mueller CR; Frank S; Schrezenmeier H; Fuerst D; Mytilineos J
Front Immunol; 2020; 11():614976. PubMed ID: 33569061
[TBL] [Abstract][Full Text] [Related]
4. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
[TBL] [Abstract][Full Text] [Related]
5. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
Pidala J; Lee SJ; Ahn KW; Spellman S; Wang HL; Aljurf M; Askar M; Dehn J; Fernandez Viña M; Gratwohl A; Gupta V; Hanna R; Horowitz MM; Hurley CK; Inamoto Y; Kassim AA; Nishihori T; Mueller C; Oudshoorn M; Petersdorf EW; Prasad V; Robinson J; Saber W; Schultz KR; Shaw B; Storek J; Wood WA; Woolfrey AE; Anasetti C
Blood; 2014 Oct; 124(16):2596-606. PubMed ID: 25161269
[TBL] [Abstract][Full Text] [Related]
6. Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.
Weisdorf DJ; Nelson G; Lee SJ; Haagenson M; Spellman S; Antin JH; Bolwell B; Cahn JY; Cervantes F; Copelan E; Gale R; Gratwohl A; Khoury HJ; McCarthy P; Marks DI; Szer J; Woolfrey A; Cortes-Franco J; Horowitz MM; Arora M;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1475-8. PubMed ID: 19822308
[TBL] [Abstract][Full Text] [Related]
7. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.
Morishima Y; Kashiwase K; Matsuo K; Azuma F; Morishima S; Onizuka M; Yabe T; Murata M; Doki N; Eto T; Mori T; Miyamura K; Sao H; Ichinohe T; Saji H; Kato S; Atsuta Y; Kawa K; Kodera Y; Sasazuki T;
Blood; 2015 Feb; 125(7):1189-97. PubMed ID: 25519752
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.
Moyer AM; Hashmi SK; Kroning CM; Kremers WK; De Goey SR; Patnaik M; Litzow M; Gastineau DA; Hogan WJ; Jacob EK; Kreuter JD; Wakefield LL; Gandhi MJ
Eur J Haematol; 2017 Sep; 99(3):275-282. PubMed ID: 28632323
[TBL] [Abstract][Full Text] [Related]
9. HLA-DPB1 mismatch and acute graft-versus host disease in HLA-identical sibling donors.
Mosaad YM; Kamel H
Egypt J Immunol; 2005; 12(2):21-8. PubMed ID: 17977207
[TBL] [Abstract][Full Text] [Related]
10. Patient HLA-DP-specific CD4+ T cells from HLA-DPB1-mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease.
Rutten CE; van Luxemburg-Heijs SA; Halkes CJ; van Bergen CA; Marijt EW; Oudshoorn M; Griffioen M; Falkenburg JH
Biol Blood Marrow Transplant; 2013 Jan; 19(1):40-8. PubMed ID: 22871556
[TBL] [Abstract][Full Text] [Related]
11. HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.
Ghobadi A; Milton DR; Gowda L; Rondon G; Chemaly RF; Hamdi A; Alousi A; Afrough A; Oran B; Ciurea S; Kebriaei P; Popat UR; Qazilbash MH; Shpall EJ; Champlin RE; Bashir Q
Curr Res Transl Med; 2019 May; 67(2):51-55. PubMed ID: 30683577
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.
Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744
[TBL] [Abstract][Full Text] [Related]
13. HLA-DPB1 matching in unrelated hematopoietic stem cell transplantation program contributes to a higher incidence of disease relapse.
Burek Kamenaric M; Maskalan M; Grubic Z; Mikulic M; Serventi Seiwerth R; Durakovic N; Vrhovac R; Stingl Jankovic K; Zunec R
Hum Immunol; 2017 Nov; 78(11-12):665-671. PubMed ID: 28887054
[TBL] [Abstract][Full Text] [Related]
14. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation.
Shaw BE; Gooley TA; Malkki M; Madrigal JA; Begovich AB; Horowitz MM; Gratwohl A; Ringdén O; Marsh SG; Petersdorf EW
Blood; 2007 Dec; 110(13):4560-6. PubMed ID: 17726164
[TBL] [Abstract][Full Text] [Related]
15. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia.
Rutten CE; van Luxemburg-Heijs SA; Griffioen M; Marijt EW; Jedema I; Heemskerk MH; Posthuma EF; Willemze R; Falkenburg JH
Leukemia; 2008 Jul; 22(7):1387-94. PubMed ID: 18418406
[TBL] [Abstract][Full Text] [Related]
16. Impact of HLA-DPB1 Matching on Outcome of Unrelated Transplant for Hematologic Malignant Diseases: A Systematic Review and Meta-analysis.
Wang Y; Xu S; Fang P
Transplant Proc; 2019; 51(6):1982-1989. PubMed ID: 31399180
[TBL] [Abstract][Full Text] [Related]
17. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation.
Petersdorf EW; Smith AG; Mickelson EM; Longton GM; Anasetti C; Choo SY; Martin PJ; Hansen JA
Blood; 1993 Apr; 81(7):1923-32. PubMed ID: 8461476
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.
Morishima Y; Sasazuki T; Inoko H; Juji T; Akaza T; Yamamoto K; Ishikawa Y; Kato S; Sao H; Sakamaki H; Kawa K; Hamajima N; Asano S; Kodera Y
Blood; 2002 Jun; 99(11):4200-6. PubMed ID: 12010826
[TBL] [Abstract][Full Text] [Related]
19. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
Morishima Y; Yabe T; Matsuo K; Kashiwase K; Inoko H; Saji H; Yamamoto K; Maruya E; Akatsuka Y; Onizuka M; Sakamaki H; Sao H; Ogawa S; Kato S; Juji T; Sasazuki T; Kodera Y;
Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
[TBL] [Abstract][Full Text] [Related]
20. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation.
Petersdorf EW; Gooley T; Malkki M; Anasetti C; Martin P; Woolfrey A; Smith A; Mickelson E; Hansen JA
Br J Haematol; 2001 Mar; 112(4):988-94. PubMed ID: 11298597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
